谷歌浏览器插件
订阅小程序
在清言上使用

Abstract CT151: Trial in Progress:A Phase 1 Trial of TSC-100 and TSC-101, Engineered T Cell Therapies That Target Minor Histocompatibility Antigens to Eliminate Residual Disease after Hematopoietic Cell Transplantation

Cancer research(2024)

引用 0|浏览12
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要